More about E.I.D.- Parry (India) Limited
Fundamentals for E.I.D.- Parry (India) Limited
Regulatory Filings for E.I.D.- Parry (India) Limited
Defence Profits Reach Dharavi's Machinists
From COVID Debt to Green Despair: Industrial Discharge Is Destroying India’s Last Prawn Nurseries
The Hidden Cost of India's Electronics Assembly Push: A 40% E-Waste Surge and the Death of Affordable Repair
The Wedding Loan Trap: How India’s Microfinance Boom Turned Housewives Into Ghost Borrowers and Temple Brass Into EMI Cash
Fundamentals for E.I.D.- Parry (India) Limited
Business Operations:
Sector: Basic MaterialsIndustry: Agricultural Inputs
E.I.D.- Parry (India) Limited, together with its subsidiaries, engages in the manufacture and sale of sugar, nutraceuticals, and distillery products in India, North America, Europe, and internationally. The company offers sugar for use in food, bakery, confectioneries, beverage, and pharmaceutical industries; and grains, such as millets and dhals, as well as rice. It also provides nutraceuticals products, such as organic spirulina and chlorella, carotenoid, astaxanthin, and lutein and zeaxanthin; and distillery products, including extra neutral alcohol, ethanol, etc. In addition, the company offers generates and sells approximately 140 MW of power for state electricity grids and private energy. E.I.D.- Parry (India) Limited was founded in 1788 and is headquartered in Chennai, India.
Revenue projections:
EIDPARRY is projected to experience a revenue decline compared to last year, a development that often leads to investor caution. The drop could negatively impact the company's bottom line, as lower revenues typically signal reduced profitability, prompting more conservative investment strategies.
Financial Ratios:
| currentRatio | 0.000000 |
|---|---|
| forwardPE | 11.139842 |
| debtToEquity | 18.388000 |
| earningsGrowth | 0.191000 |
| revenueGrowth | 0.183000 |
| grossMargins | 0.225690 |
| operatingMargins | 0.061220 |
| trailingEps | 66.760000 |
| forwardEps | 75.800000 |
EIDPARRY's Forward PE being in a good range suggests that its stock price is aligned well with earnings. The stock is not considered overpriced, offering room for future growth, which makes it an appealing investment opportunity with the potential for value appreciation.
E.I.D.- Parry (India) Limited's low Debt-to-Equity ratio shows that the company avoids excessive reliance on debt, reducing financial risk. This suggests a more secure financial position with less vulnerability to debt-related risks, making E.I.D.- Parry (India) Limited a stable and conservative investment.
EIDPARRY's positive earnings and revenue growth suggest that the company is poised for business expansion. This financial strength indicates that EIDPARRY is expected to continue growing, with rising profits and sales contributing to its long-term success.
E.I.D.- Parry (India) Limited's forward EPS being higher than its trailing EPS signals anticipated growth in profitability for the current financial year. This suggests that E.I.D.- Parry (India) Limited is on track to improve its earnings, outpacing the previous year's performance and reflecting positive market expectations.
Price projections:
The present price of EIDPARRY in relation to its projections indicates a lack of clear risks or opportunities. This balanced situation suggests that investors may find it prudent to wait for further signals before making significant moves in the stock.
Recommendation changes over time:
The recent buy bias for EIDPARRY from analysts signals strong confidence in the stock's potential. This positive sentiment could encourage investors to see EIDPARRY as a smart place to invest their money, especially those looking for stable, long-term returns in a well-established company.
DISCLAIMER: We provide information and our musings based on events, but nothing on this site can be considered professional advice of any kind.
If you have enjoyed reading, spread the word:
Good prospects:
Companies with the best and the worst fundamentals.
Latest Regulatory Filings for NSE500
Companies with the best and the worst technicals.
From Lifesaving Drugs to Sick Units: The Hidden Energy Crisis Inside India’s Pharma Clusters
From Price Pressures to Profit Power: The MSME Playbook Redefining India’s Economy
₹90 Crore Bet Signals a Massive Shift in India’s Rural Economy